These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33756211)

  • 21. Fetal brain disruption sequence versus fetal brain arrest: A distinct autosomal recessive developmental brain malformation phenotype.
    Abdel-Salam GM; Abdel-Hamid MS; El-Khayat HA; Eid OM; Saba S; Farag MK; Saleem SN; Gaber KR
    Am J Med Genet A; 2015 May; 167A(5):1089-99. PubMed ID: 25755095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.
    Srour M; Hamdan FF; Gan-Or Z; Labuda D; Nassif C; Oskoui M; Gana-Weisz M; Orr-Urtreger A; Rouleau GA; Michaud JL
    Clin Genet; 2015 Jul; 88(1):e1-4. PubMed ID: 25930971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. El-Hattab-Alkuraya syndrome caused by biallelic WDR45B pathogenic variants: Further delineation of the phenotype and genotype.
    Almannai M; Marafi D; Abdel-Salam GMH; Zaki MS; Duan R; Calame D; Herman I; Levesque F; Elbendary HM; Hegazy I; Chung WK; Kavus H; Saeidi K; Maroofian R; AlHashim A; Al-Otaibi A; Al Madhi A; Abou Al-Seood HM; Alasmari A; Houlden H; Gleeson JG; Hunter JV; Posey JE; Lupski JR; El-Hattab AW
    Clin Genet; 2022 May; 101(5-6):530-540. PubMed ID: 35322404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRAT1 mutations present with a spectrum of clinical severity.
    Srivastava S; Olson HE; Cohen JS; Gubbels CS; Lincoln S; Davis BT; Shahmirzadi L; Gupta S; Picker J; Yu TW; Miller DT; Soul JS; Poretti A; Naidu S
    Am J Med Genet A; 2016 Sep; 170(9):2265-73. PubMed ID: 27282546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome.
    Masurel-Paulet A; Piton A; Chancenotte S; Redin C; Thauvin-Robinet C; Henrenger Y; Minot D; Creppy A; Ruffier-Bourdet M; Thevenon J; Kuentz P; Lehalle D; Curie A; Blanchard G; Ghosn E; Bonnet M; Archimbaud-Devilliers M; Huet F; Perret O; Philip N; Mandel JL; Faivre L
    Am J Med Genet A; 2016 Aug; 170(8):2103-10. PubMed ID: 27256868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes.
    Valence S; Garel C; Barth M; Toutain A; Paris C; Amsallem D; Barthez MA; Mayer M; Rodriguez D; Burglen L
    Clin Genet; 2016 Dec; 90(6):545-549. PubMed ID: 27000652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy.
    Evers C; Kaufmann L; Seitz A; Paramasivam N; Granzow M; Karch S; Fischer C; Hinderhofer K; Gdynia G; Elsässer M; Pinkert S; Schlesner M; Bartram CR; Moog U
    Am J Med Genet A; 2016 Jun; 170(6):1502-9. PubMed ID: 27016154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy.
    Moortgat S; Désir J; Benoit V; Boulanger S; Pendeville H; Nassogne MC; Lederer D; Maystadt I
    Am J Med Genet A; 2016 Nov; 170(11):2927-2933. PubMed ID: 27333055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the phenotypic spectrum associated with OPHN1 mutations: Report of 17 individuals with intellectual disability but no cerebellar hypoplasia.
    Moortgat S; Lederer D; Deprez M; Buzatu M; Clapuyt P; Boulanger S; Benoit V; Mary S; Guichet A; Ziegler A; Colin E; Bonneau D; Maystadt I
    Eur J Med Genet; 2018 Aug; 61(8):442-450. PubMed ID: 29510240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia.
    Meng L; Isohanni P; Shao Y; Graham BH; Hickey SE; Brooks S; Suomalainen A; Joset P; Steindl K; Rauch A; Hackenberg A; High FA; Armstrong-Javors A; Mencacci NE; Gonzàlez-Latapi P; Kamel WA; Al-Hashel JY; Bustos BI; Hernandez AV; Krainc D; Lubbe SJ; Van Esch H; De Luca C; Ballon K; Ravelli C; Burglen L; Qebibo L; Calame DG; Mitani T; Marafi D; Pehlivan D; Saadi NW; Sahin Y; Maroofian R; Efthymiou S; Houlden H; Maqbool S; Rahman F; Gu S; Posey JE; Lupski JR; Hunter JV; Wangler MF; Carroll CJ; Yang Y
    Ann Neurol; 2021 Apr; 89(4):828-833. PubMed ID: 33443317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.
    Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E
    J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible genotype-phenotype correlation in Ashkenazi-Jewish individuals with Aicardi-Goutières syndrome associated with SAMHD1 mutation.
    Straussberg R; Marom D; Sanado-Inbar E; Lakovsky Y; Horev G; Shalev SA; Lev D; Lerman-Sagie T; Leshinsky-Silver E
    J Child Neurol; 2015 Mar; 30(4):490-5. PubMed ID: 25246298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.
    Kaiyrzhanov R; Rad A; Lin SJ; Bertoli-Avella A; Kallemeijn WW; Godwin A; Zaki MS; Huang K; Lau T; Petree C; Efthymiou S; Karimiani EG; Hempel M; Normand EA; Rudnik-Schöneborn S; Schatz UA; Baggelaar MP; Ilyas M; Sultan T; Alvi JR; Ganieva M; Fowler B; Aanicai R; Tayfun GA; Al Saman A; Alswaid A; Amiri N; Asilova N; Shotelersuk V; Yeetong P; Azam M; Babaei M; Monajemi GB; Mohammadi P; Samie S; Banu SH; Pinto Basto J; Kortüm F; Bauer M; Bauer P; Beetz C; Garshasbi M; Issa AH; Eyaid W; Ahmed H; Hashemi N; Hassanpour K; Herman I; Ibrohimov S; Abdul-Majeed BA; Imdad M; Isrofilov M; Kaiyal Q; Khan S; Kirmse B; Koster J; Lourenço CM; Mitani T; Moldovan O; Murphy D; Najafi M; Pehlivan D; Rocha ME; Salpietro V; Schmidts M; Shalata A; Mahroum M; Talbeya JK; Taylor RW; Vazquez D; Vetro A; Waterham HR; Zaman M; Schrader TA; Chung WK; Guerrini R; Lupski JR; Gleeson J; Suri M; Jamshidi Y; Bhatia KP; Vona B; Schrader M; Severino M; Guille M; Tate EW; Varshney GK; Houlden H; Maroofian R
    Brain; 2024 Apr; 147(4):1436-1456. PubMed ID: 37951597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded PCH1D phenotype linked to EXOSC9 mutation.
    Bizzari S; Hamzeh AR; Mohamed M; Al-Ali MT; Bastaki F
    Eur J Med Genet; 2020 Jan; 63(1):103622. PubMed ID: 30690203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two microcephaly-associated novel missense mutations in CASK specifically disrupt the CASK-neurexin interaction.
    LaConte LEW; Chavan V; Elias AF; Hudson C; Schwanke C; Styren K; Shoof J; Kok F; Srivastava S; Mukherjee K
    Hum Genet; 2018 Mar; 137(3):231-246. PubMed ID: 29426960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.
    Yi Z; Zhang Y; Song Z; Pan H; Yang C; Li F; Xue J; Qu Z
    Ital J Pediatr; 2020 Jul; 46(1):95. PubMed ID: 32646507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the spectrum of CEP55-associated disease to viable phenotypes.
    Barrie ES; Overwater E; van Haelst MM; Motazacker MM; Truxal KV; Crist E; Mostafavi R; Pivnick EK; Choudhri AF; Narumanchi T; Castelluccio V; Walsh LE; Garganta C; Gastier-Foster JM
    Am J Med Genet A; 2020 May; 182(5):1201-1208. PubMed ID: 32100459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.
    Kortüm F; Jamra RA; Alawi M; Berry SA; Borck G; Helbig KL; Tang S; Huhle D; Korenke GC; Hebbar M; Shukla A; Girisha KM; Steinlin M; Waldmeier-Wilhelm S; Montomoli M; Guerrini R; Lemke JR; Kutsche K
    Eur J Hum Genet; 2018 May; 26(5):695-708. PubMed ID: 29463858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.